Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DelveInsight | PRODUCT CODE: 2082800

Cover Image

PUBLISHER: DelveInsight | PRODUCT CODE: 2082800

Asphyxia - Epidemiology Forecast - 2036

PUBLISHED:
PAGES: 60 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 3990
PDF & Excel (2-3 User License)
USD 4988
PDF & Excel (Site License)
USD 6982
PDF & Excel (Global License)
USD 8977

Add to Cart

Key Highlights:

  • Asphyxia is a life-threatening condition characterized by inadequate oxygen delivery to tissues, resulting in cellular hypoxia, metabolic dysfunction, and potential multi-organ failure. It may arise from airway obstruction, respiratory compromise, environmental oxygen deprivation, or conditions that impair oxygen transport and utilization. Without prompt intervention, severe asphyxia can lead to irreversible neurological injury or death.
  • Early recognition remain critical determinants of outcome. Delays in diagnosis, resuscitation, or restoration of adequate oxygenation are associated with increased mortality and a higher risk of long-term neurological sequelae.
  • Epidemiological evidence suggests a higher incidence among males than females, with a substantial proportion of affected individuals having underlying chronic comorbidities
  • Many patients surviving severe asphyxia continue to experience long-term complications such as cognitive impairment, seizures, and motor dysfunction. Lack of standardized biomarkers and prognostic tools for early assessment of neurological injury severity and recovery potential.

Asphyxia Syndrome Epidemiology Forecast in the 7MM

DelveInsight's 'Asphyxia - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the asphyxia, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Asphyxia Understanding and Diagnosis

Asphyxia Overview and Diagnosis

Asphyxia is a serious and potentially fatal condition caused by inadequate oxygen supply to the body, resulting in impaired tissue function and possible organ damage. It may occur due to airway blockage, respiratory insufficiency, reduced environmental oxygen, or disruption of oxygen transport within the bloodstream. Without immediate medical intervention, prolonged oxygen deprivation can lead to permanent brain injury, multiorgan failure, or death. Asphyxia can develop in both acute and chronic forms and is commonly associated with conditions such as choking, drowning, strangulation, suffocation, toxic gas inhalation, severe respiratory disorders, and neuromuscular diseases affecting breathing.

Diagnosis of asphyxia is primarily clinical and requires rapid assessment of airway patency, breathing, circulation, oxygen saturation, and neurological status. Pulse oximetry is commonly used to evaluate oxygenation, while arterial blood gas (ABG) analysis helps assess hypoxemia, hypercapnia, and acid-base disturbances. Additional investigations may include chest radiography, CT imaging, bronchoscopy, or other tests to identify underlying causes such as airway obstruction, pulmonary disease, or trauma. In cases of suspected toxic exposure, specific laboratory tests (e.g., carboxyhemoglobin levels for carbon monoxide poisoning) may be performed. For neonatal asphyxia, diagnosis is supported by low Apgar scores, umbilical cord blood gas analysis, evidence of metabolic acidosis, and signs of multi-organ dysfunction.

Asphyxia Epidemiology

Key Findings from Asphyxia Epidemiological Analysis and Forecast

  • As per secondary analysis, males are more common than females, and most patients had chronic conditions.
  • As per secondary analysis, the incidence of suffocation injuries treated in emergency departments was approximately 20 per 100,000 individuals.
  • According to the secondary search, inhalation and ingestion of food causing obstruction of respiratory tract or suffocation was the most common presentation (51.6%), followed by suicide and self-inflicted injury by hanging, strangulation, and suffocation (39.3%).

Scope of the Report:

  • The report covers a segment of key events, an executive summary, a descriptive overview of asphyxia, explaining its causes, signs and symptoms, and pathogenesis.
  • Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

Asphyxia Patient Population Forecast

Report Key Strengths

  • Epidemiology-based (Epi-based) Bottom-up Forecasting
  • Artificial Intelligence (AI)-Enabled Market Research Report
  • 11-Year Forecast

FAQs:

  • What are the disease risks, burdens, and unmet needs of asphyxia? What will be the growth opportunities across the 7MM concerning the patient population with asphyxia?
  • What is the asphyxia incidence in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
  • What is the historical and forecasted asphyxia patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy:

  • Insights on asphyxia burden and disease incidence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
  • To understand key opinion leaders' perspectives around the diagnostic challenges to overcome barriers in the future.
  • Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
  • Clear methodology, validated assumptions, and data-driven rationale to assess the asphyxia epidemiology analysis and patient population trends.
Product Code: DIEI1171

Table of Contents

1. Key Insights

2. Report Introduction

3. Executive Asphyxia

4. Asphyxia Epidemiology Forecast Methodology

5. Asphyxia Patient Overview at a Glance

  • 5.1. Asphyxia Patient Share (%) Distribution by Country in 2025 in the 7MM
  • 5.2. Asphyxia Patient Share (%) Distribution by Country in 2036 in the 7MM

6. Disease Background and Overview

  • 6.1. Introduction
  • 6.2. Cause and Inheritance
  • 6.3. Signs and Symptoms
  • 6.4. Complications
  • 6.5. Pathophysiology
  • 6.6. Diagnosis
    • 6.6.1. Differential Diagnosis
    • 6.6.2. Diagnosis Algorithm
    • 6.6.3. Diagnosis Guidelines

7. Epidemiology and Patient Population of Asphyxia

  • 7.1. Key Findings
  • 7.2. Assumptions and Rationale
  • 7.3. Asphyxia Incident Cases in the 7MM
  • 7.4. The United States
    • 7.4.1. Total Incident Cases of Asphyxia in the US
    • 7.4.2. Age-specific Diagnosed Cases of Asphyxia in the US
    • 7.4.3. Gender specific Cases of Asphyxia in the US
  • 7.5. EU4 and the UK
    • 7.5.1. Total Incident Cases of Asphyxia in EU4 and the UK
    • 7.5.2. Age-specific Diagnosed Cases of Asphyxia in EU4 and the UK
    • 7.5.3. Gender specific Cases of Asphyxia in EU4 and the UK
  • 7.6. Japan
    • 7.6.1. Total Incident Cases of Asphyxia in Japan
    • 7.6.2. Age-specific Diagnosed Cases of Asphyxia in Japan
    • 7.6.3. Gender specific Cases of Asphyxia in Japan

8. Patient Journey

9. KOL

10. Appendix

  • 10.1. Bibliography
  • 10.2. Report Methodology

11. DelveInsight Capabilities

12. Disclaimer

13. About DelveInsight

Product Code: DIEI1171

List of Tables

  • Table 1: Summary of Asphyxia Epidemiology
  • Table 2: Common Signs and Symptoms Observed in Patients with Asphyxia
  • Table 3: Total Incident Cases of Asphyxia in the US (2022-2036)
  • Table 4: Age-Specific Diagnosed Cases of Asphyxia in the US (2022-2036)
  • Table 5: Gender Specific Diagnosed Cases of Asphyxia in the US (2022-2036)
  • Table 6: Total Incident Cases of Asphyxia in EU4 and UK (2022-2036)
  • Table 7: Age-Specific Diagnosed Cases of Asphyxia in EU4 and UK (2022-2036)
  • Table 8: Gender Specific Diagnosed Cases of Asphyxia in EU4 and UK (2022-2036)
  • Table 9: Total Incident Cases of Asphyxia in Japan (2022-2036)
  • Table 10: Age-Specific Diagnosed Cases of Asphyxia in Japan (2022-2036)
  • Table 11: Gender Specific Diagnosed Cases of Asphyxia in Japan (2022-2036)

List of Figures

  • Figure 1: Diagnostic Algorithm
  • Figure 2: Total Incident Cases of Asphyxia in 7MM (2022-2036)
  • Figure 3: Total Incident Cases of Asphyxia in the US (2022-2036)
  • Figure 4: Age-Specific Diagnosed Cases of Asphyxia in the US (2022-2036)
  • Figure 5: Gender Specific Diagnosed Cases of Asphyxia in the US (2022-2036)
  • Figure 6: Total Incident Cases of Asphyxia in EU4 and UK (2022-2036)
  • Figure 7: Age-Specific Diagnosed Cases of Asphyxia in EU4 and UK (2022-2036)
  • Figure 8: Gender Specific Diagnosed Cases of Asphyxia in EU4 and UK (2022-2036)
  • Figure 9: Total Incident Cases of Asphyxia in Japan (2022-2036)
  • Figure 10: Age-Specific Diagnosed Cases of Asphyxia in Japan (2022-2036)
  • Figure 11: Gender Specific Diagnosed Cases of Asphyxia in Japan (2022-2036)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!